TR201909817T4 - Hi̇perkolesterolemi̇ tedavi̇si̇ i̇çi̇n tibbi̇ formülasyon - Google Patents

Hi̇perkolesterolemi̇ tedavi̇si̇ i̇çi̇n tibbi̇ formülasyon Download PDF

Info

Publication number
TR201909817T4
TR201909817T4 TR2019/09817T TR201909817T TR201909817T4 TR 201909817 T4 TR201909817 T4 TR 201909817T4 TR 2019/09817 T TR2019/09817 T TR 2019/09817T TR 201909817 T TR201909817 T TR 201909817T TR 201909817 T4 TR201909817 T4 TR 201909817T4
Authority
TR
Turkey
Prior art keywords
medical formulation
treatment
hypercholesterolemia
relates
medical
Prior art date
Application number
TR2019/09817T
Other languages
English (en)
Inventor
Taal Leendert
Monique Tal-Vlas Anita
Original Assignee
Taal Vlas Anita Monique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taal Vlas Anita Monique filed Critical Taal Vlas Anita Monique
Publication of TR201909817T4 publication Critical patent/TR201909817T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut buluş, aşağıdakileri içeren tıbbi bir formülasyon ile ilgilidir: cinnamomum zeylanicum; Pinus pinaster; Saccharum cinsine ait bir bitkinin özü; Monascus purpureus; Taraxacum officinale; Camellia sinensis; B3 vitamini; alfa tokoferol; koenzim Q10; eikosapentaenoik asit ve dokosaheksanoik asit içeren balık yağı; Beta-glukan; ve / veya kolekalsiferol. Buluş ayrıca, özellikle hiperkolesteroleminin tedavisi için bir ilaç ve tıbbi formülasyon ile de ilgilidir.
TR2019/09817T 2012-12-27 2013-12-24 Hi̇perkolesterolemi̇ tedavi̇si̇ i̇çi̇n tibbi̇ formülasyon TR201909817T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2010065 2012-12-27

Publications (1)

Publication Number Publication Date
TR201909817T4 true TR201909817T4 (tr) 2019-07-22

Family

ID=49943471

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/09817T TR201909817T4 (tr) 2012-12-27 2013-12-24 Hi̇perkolesterolemi̇ tedavi̇si̇ i̇çi̇n tibbi̇ formülasyon

Country Status (12)

Country Link
US (1) US9655942B2 (tr)
EP (2) EP2938350B1 (tr)
AU (1) AU2013368749B2 (tr)
CA (1) CA2895069C (tr)
DK (1) DK2938350T3 (tr)
ES (2) ES2926725T3 (tr)
HR (1) HRP20190705T1 (tr)
HU (1) HUE044796T2 (tr)
PL (1) PL2938350T3 (tr)
SI (1) SI2938350T1 (tr)
TR (1) TR201909817T4 (tr)
WO (1) WO2014104884A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109195596A (zh) * 2016-04-14 2019-01-11 迈克尔·露西 组合物及其使用方法
US10183053B1 (en) 2017-06-19 2019-01-22 Gene S. Rosen Multi-component formulations
US10004757B1 (en) 2017-09-22 2018-06-26 Nutri Vida, LLC Oral supplement
CN113633664A (zh) * 2021-09-22 2021-11-12 泉州雷恩生化有限公司 用于治疗心房和心室的早博的胶囊及其制作方法
WO2024003377A1 (en) 2022-07-01 2024-01-04 N.V. Nutricia Nutritional composition for stroke

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1081235C (zh) * 1998-12-04 2002-03-20 陈远德 具有保健作用的食用糖
KR100377313B1 (ko) * 2000-03-22 2003-03-26 (주)현덕비엔티 녹차 추출물의 제조방법
US6436406B1 (en) * 2000-06-15 2002-08-20 A. Glenn Braswell Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
JP2006206472A (ja) * 2005-01-27 2006-08-10 Ogawa & Co Ltd コレステロール排出促進剤
US8202546B2 (en) * 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
JP2008125485A (ja) * 2006-11-24 2008-06-05 Ivy Cosmetics Corp ドコサヘキサエン酸含有加工食品
FR2936711B1 (fr) * 2008-10-06 2012-09-21 Holymark Composition orale, en particulier complement alimentaire comprenant un extrait sec de feuilles d'artichaut et de la levure de riz rouge
US8114445B2 (en) * 2008-11-07 2012-02-14 Reliv International Inc. Dietary supplement for promoting wellness and weight loss and methods of administering the same
ITPI20110038A1 (it) * 2011-04-08 2012-10-09 Funcional Food Res S R L Composizione alimentare funzionale a base di farina.

Also Published As

Publication number Publication date
AU2013368749A1 (en) 2015-07-02
US9655942B2 (en) 2017-05-23
EP3536331B1 (en) 2022-08-10
ES2926725T3 (es) 2022-10-27
HUE044796T2 (hu) 2019-11-28
DK2938350T3 (da) 2019-07-15
EP2938350A1 (en) 2015-11-04
CA2895069A1 (en) 2014-07-03
SI2938350T1 (sl) 2019-05-31
US20150328276A1 (en) 2015-11-19
HRP20190705T1 (hr) 2019-07-12
PL2938350T3 (pl) 2019-09-30
AU2013368749B2 (en) 2018-04-05
CA2895069C (en) 2021-04-06
EP2938350B1 (en) 2019-04-03
WO2014104884A1 (en) 2014-07-03
ES2729792T3 (es) 2019-11-06
EP3536331A1 (en) 2019-09-11

Similar Documents

Publication Publication Date Title
TR201909817T4 (tr) Hi̇perkolesterolemi̇ tedavi̇si̇ i̇çi̇n tibbi̇ formülasyon
TR201905586T4 (tr) Amorf dapagli̇flozi̇n i̇çeren formülasyonlar
PH12016501965A1 (en) S1p modulator immediate release dosage regimen
MY176018A (en) Composition useful for the treatment of lipid metabolism disorders
WO2013114394A8 (en) A polyherbal composition for skin care
TR201902517T4 (tr) 25-hidroksivitamin D3 ile artan eotaksin ile ilişkilendirilen durumların tedavi edilmesi.
IN2014MN01973A (tr)
PH12015502108A1 (en) Pharmaceutical combination drug
CL2012002893A1 (es) Composición de al menos un ingrediente activo de origen vegetal o sintético análogo del mismo, o extracto de origen vegetal que lo contiene, en una solución acuosa, que además comprende lecitina como agente encapsulante; medicamento que la comprende; método para su preparación; y su uso para tratar parasitosis intestinales.
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
NZ709664A (en) Use of fenugreek extract to enhance female libido
BR112013026933A2 (pt) uso de uma combinação de pelo menos um carotenoide
MX2016001686A (es) Composicion para el tratamiento contra el envejecimiento de la piel.
BR112012020223B8 (pt) pélete farmacêutico de fator de crescimento epidérmico administrável por via oral, uso e processo de preparação do mesmo, bem como cápsula compreendendo o referido pélete
TN2015000142A1 (en) Use of pidotimod to treat psoriasis
WO2012134250A3 (ko) 감송향 추출물을 포함하는 신장암 치료용 조성물 및 화장료 조성물
WO2012134251A3 (ko) 감송향 추출물을 포함하는 췌장암 치료용 조성물 및 화장료 조성물
AR089136A1 (es) Variantes de osteopontina para usar en la supresion o prevencion del crecimiento tumoral y composiciones que las contienen
WO2013002522A3 (ko) 마스티시아 알보리아 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 조성물
WO2012067398A3 (ko) 산속단 추출물을 유효성분으로 함유하는 피부 미백용 조성물
WO2014005818A3 (de) Wirkstoffkombinationen aus magnolienrindenextrakt und hyaluronsäure und ihre kosmetische und/oder dermatologische verwendung
MX368553B (es) Composicion cicatrizante a base de tio2 y tournefortia hirsutissima.
Nankar et al. Ellagic Acid Interacts Synergistically With Pioglitazone To Enhance Insulin Stimulated 2-NBDG Uptake In 3T3L1 Adipocytes
UA63236U (ru) Концентрированный экстракт гибискуса для лечения или профилактики инфекционных заболеваний мочевыводящих путей
UA100942C2 (ru) Лекарственное средство из пчелиных и растительных продуктов